Forte Capital LLC Edwards Lifesciences Corp Transaction History

Forte Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $6,788 - $8,553	-110 Reduced 2.13%	5,046 $384,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $7,967 - $10,738	-115 Reduced 2.18%	5,156 $357,000
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $1,058 - $1,226	-13 Reduced 0.25%	5,271 $497,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $1,485 - $1,690	20 Added 0.38%	5,284 $437,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $17,962 - $22,996	263 Added 5.26%	5,264 $392,000
Q3 2022 Oct 21, 2022	BUY	$82.37 - $107.29 $15,650 - $20,385	190 Added 3.95%	5,001 $413,000
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $86 - $128	1 Added 0.02%	4,811 $457,000
Q4 2021 Jan 20, 2022	BUY	$106.37 - $130.68 $1,595 - $1,960	15 Added 0.31%	4,810 $623,000
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $2,572 - $3,068	25 Added 0.52%	4,795 $543,000
Q2 2021 Jul 28, 2021	BUY	$83.84 - $104.76 $12,576 - $15,714	150 Added 3.25%	4,770 $494,000
Q1 2021 Apr 22, 2021	BUY	$78.68 - $90.67 $44,611 - $51,409	567 Added 13.99%	4,620 $386,000
Q4 2020 Jan 19, 2021	BUY	$71.69 - $91.23 $290,559 - $369,755	4,053 New	4,053 $370,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

Stay updated on Forte Capital LLC with notifications on news.